Mediterranean plant may be an effective treatment for ulcerative colitis, rat study shows

	Ulcerative Colitis
	The latest ulcerative colitis news from News Medical

	Mediterranean plant may be an effective treatment for ulcerative colitis, rat study shows New research in rats indicates that a Mediterranean plant may be an effective treatment for ulcerative colitis, a type of inflammatory bowel disease.

	ADHD linked to higher risk of irritable bowel syndrome, global study reveals A global meta-analysis found that people with ADHD are significantly more likely to have irritable bowel syndrome (IBS), while the overall risk for other intestinal disorders is not increased. The findings highlight the importance of gut-brain interactions in ADHD and call for further research on microbiome-based therapies.

			Global study maps the spread of IBD in Africa, Asia, and Latin America Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, has long been considered a modern condition of the industrialized West, with cases steadily increasing in North America and Europe throughout the 20th century.

			Upper gastrointestinal involvement is common in Egyptian patients with ulcerative colitis This study investigates upper gastrointestinal tract (UGIT) involvement in patients with ulcerative colitis (UC), a condition traditionally considered limited to the colon.

	TMEM219 inhibition shows promise in restoring intestinal health in IBD An international study led by Paolo Fiorina from Boston Children's Hospital and in collaboration with researchers from University of Milan highlights the beneficial effect of inhibiting the death receptor TMEM219 to restore mucosal healing in inflammatory bowel diseases.

	New biomarkers could help improve detection and treatment of gastrointestinal diseases Scientists have discovered a range of 'biomarkers' that could help to improve detection and treatment of gastrointestinal diseases (GIDs) such as gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease (IBD).

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025